MY112586A - Isoxazoline compounds as 5-lipoxygenase inhibitors - Google Patents

Isoxazoline compounds as 5-lipoxygenase inhibitors

Info

Publication number
MY112586A
MY112586A MYPI95000574A MYPI19950574A MY112586A MY 112586 A MY112586 A MY 112586A MY PI95000574 A MYPI95000574 A MY PI95000574A MY PI19950574 A MYPI19950574 A MY PI19950574A MY 112586 A MY112586 A MY 112586A
Authority
MY
Malaysia
Prior art keywords
isoxazoline compounds
lipoxygenase inhibitors
relates
dermatitis
lipoxygenase
Prior art date
Application number
MYPI95000574A
Other languages
English (en)
Inventor
F Kleinman Edward
L Cohan Victoria
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY112586A publication Critical patent/MY112586A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MYPI95000574A 1994-03-09 1995-03-07 Isoxazoline compounds as 5-lipoxygenase inhibitors MY112586A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20876894A 1994-03-09 1994-03-09

Publications (1)

Publication Number Publication Date
MY112586A true MY112586A (en) 2001-07-31

Family

ID=22775981

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI95000574A MY112586A (en) 1994-03-09 1995-03-07 Isoxazoline compounds as 5-lipoxygenase inhibitors

Country Status (11)

Country Link
US (1) US5696141A (fr)
EP (1) EP0749307A1 (fr)
JP (1) JPH09505081A (fr)
AU (1) AU1326795A (fr)
CA (1) CA2184914C (fr)
FI (1) FI963509A7 (fr)
IL (1) IL112849A (fr)
MX (1) MX9603943A (fr)
MY (1) MY112586A (fr)
WO (1) WO1995024192A1 (fr)
ZA (1) ZA951911B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62103070A (ja) * 1985-10-29 1987-05-13 Mitsui Toatsu Chem Inc イソオキサゾリン誘導体および植物生長調節剤
HU215433B (hu) * 1986-04-29 2000-05-28 Pfizer Inc. Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
IE59813B1 (en) * 1986-05-09 1994-04-06 Warner Lambert Co Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
IL92915A0 (en) * 1989-01-05 1990-09-17 Ciba Geigy Ag Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
CA2017383A1 (fr) * 1989-06-08 1990-12-08 Raymond R. Martodam Utilisation de vanilloides pour le traitement des affections ou des troubles respiratoires
WO1991007177A1 (fr) * 1989-11-13 1991-05-30 Pfizer Inc. Derives de pyrimidone et analogues pour le traitement de l'asthme et de certaines maladies de la peau
DE3939010A1 (de) * 1989-11-25 1991-05-29 Hoechst Ag Isoxazoline, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschuetzende mittel
JP2787602B2 (ja) * 1990-01-24 1998-08-20 大鵬薬品工業株式会社 イソキサゾリン誘導体
US5234937A (en) * 1990-03-27 1993-08-10 Warner-Lambert Company 3,5-di-tertiary-butyl-4-hydroxphenyl oxazolyl methanones and related compounds as antiinflammatory agents
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
KR930703262A (ko) * 1990-11-06 1993-11-29 스튜어트 알. 슈터 이미다졸리디논 화합물
PT100441A (pt) * 1991-05-02 1993-09-30 Smithkline Beecham Corp Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
GB9215921D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Anti-inflammatory compounds
US5288397A (en) * 1992-09-18 1994-02-22 Mobil Oil Corporation Baffled FCC regeneration process and apparatus
WO1994018158A1 (fr) * 1993-02-15 1994-08-18 Pfizer Inc. Spiroalkylhydroxyurees utilisees comme inhibiteurs de lipoxygenase

Also Published As

Publication number Publication date
EP0749307A1 (fr) 1996-12-27
JPH09505081A (ja) 1997-05-20
US5696141A (en) 1997-12-09
WO1995024192A1 (fr) 1995-09-14
CA2184914C (fr) 2000-09-19
CA2184914A1 (fr) 1995-09-14
AU1326795A (en) 1995-09-25
IL112849A (en) 1999-04-11
FI963509L (fi) 1996-09-06
FI963509A0 (fi) 1996-09-06
IL112849A0 (en) 1995-06-29
MX9603943A (es) 1997-04-30
ZA951911B (en) 1996-09-09
FI963509A7 (fi) 1996-09-06

Similar Documents

Publication Publication Date Title
FI945556A0 (fi) Tulehdustenvastaiset 3-aryyli-2-isoksatsoliinijohdannaiset
CA2176255A1 (fr) Composes d'isoxazoline utiles comme agents anti-inflammatoires
FI945555A0 (fi) Substituoituja oksindoleja
IL139828A0 (en) COMPOUNDS HAVING IgE AFFECTING PROPERTIES
WO2007036745A3 (fr) Composition comprenant un anticorps anti-interleukine 13
NO963746L (no) Isoksalin-forbindelser som inhibitorer for frigivning av TNF
IL232210A0 (en) New anti-13 il antibodies and their uses
WO2005123692A8 (fr) Derives de pyridazin-3(2h)-one et leur utilisation en tant qu'inhibiteurs de la pde4
MXPA05012086A (es) Inhibidores de benzamida del receptor p2x7.
EP1000930A3 (fr) Antagonistes de tachykinines
IL107758A0 (en) Catechol diethers as selective pde inhibitors
WO1999065449A8 (fr) INHIBITEURS DU FACTEUR DE TRANSCRIPTION NF-λB
TW200610757A (en) New pyridazin-3(2H)-one derivatives
IS6444A (is) Pýrimidín karboxamíð nytsamleg sem latar á PDE4 samsætuensím
BG103725A (en) Nicotineamide derivatives
MXPA04004300A (es) Analogos de lipoxina a4.
DK0980374T3 (da) Phosphodiesterase 4-inhiberende diazepinoindoloner.
WO2005016893A3 (fr) Methodes de traitement ou de prevention de maladies auto-immunes a l'aide de composes de 2,4-pyrimidinediamine
SE9900833D0 (sv) Novel combination
CA2186513A1 (fr) Derives benzisothiazoles en tant qu'inhibiteurs de la biosynthese de la 5-lipoxygenase
CA2184914A1 (fr) Composes d'isoxazoline agissant comme inhibiteurs de 5-lipoxygenase
WO2007062318A3 (fr) Composes chimiques
WO2002083700A3 (fr) Disaccharides hypersulfates et leur utilisation en traitement contre les inflammations
CA2184604A1 (fr) Carbamates bicycliques